Cholestech Corporation Announces the Appointment of Jeffrey S. Aroy As Chief Operating Officer -- WellCheck.com.

HAYWARD, Calif.--(BW HealthWire)--Nov. 30, 1999--

Cholestech Corporation (Nasdaq:CTEC) today announced that Jeffrey S. Aroy has joined the Company as Corporate Vice President with responsibility as Chief Operating Officer for the WellCheck.com business unit.

Aroy comes to Cholestech from IBM, where he held the positions of Principal and Practice Leader for the Wilkerson Group -- IBM's global healthcare consulting organization. Additionally, Aroy was the Head of West Coast Healthcare Consulting for the Wilkerson Group and led IBM's eBusiness push in the healthcare market space.

Commenting on Aroy's appointment, Warren E. Pinckert II, President and Chief Executive Officer said, "We are extremely pleased to be able to add Jeff's skills and knowledge to our management team as we execute our expansion plans in the eBusiness arena. Jeff and his team at the Wilkerson Group have been of strategic importance to Cholestech as we have developed our broader personal health management initiatives. His extensive experience in the broader healthcare markets, combined with his knowledge of IBM's world-class Internet services, adds critical execution-power to Cholestech's WellCheck.com Internet business strategy."

Aroy received an A.B. degree from Harvard College, Cum Laude and is a graduate of the Wharton School, from which he received an MBA in Strategic Management. Aroy's experience also includes positions with Deloitte & Touche Management Consulting, Bank of Tokyo Financial Corporation, AT&T, and Fidelity Investments.

About Cholestech

Cholestech is committed to helping people successfully improve their health. Working together, the Cholestech business units of WellCheck, WellCheck.com, and Diagnostic Products, can provide simple, accessible, and reliable personal health information to health care practitioners and directly to consumers in over 35 countries around the world.

By offering efficient and economic diagnostic screening for cholesterol, blood sugar, and liver function, Cholestech hopes to help more people understand whether or not they face potentially serious health risks. Therapeutic monitoring options using the Cholestech L.D.X(R) System can help patients monitor their progress as they work with their health care provider to reduce their risk of cardiovascular and other diseases. Working together with health care providers, our goal is to ultimately enable people to lead longer, healthier, and more active lives.

Safe Harbor Statement of Cholestech Corporation under the Private

Securities Litigation Reform Act of 1995:

This release may contain forward-looking statements based on Cholestech's current expectations, estimates, and projections about Cholestech's industry, management's beliefs, and certain assumptions made by Cholestech. Words such as "anticipates," "expects," "intends," "plans," "believes," "may," "will," and similar expressions are intended to identify forward-looking statements. Forward-looking statements in this release include statements regarding the ability of Cholestech's WellCheck.com businesses to successfully provide personal health management and help identify potential health risks and monitor therapy. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, Cholestech's actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors.

There are several major risks created by Cholestech's pursuit of its new strategy. These risks include the following:

Cholestech has no experience in the Testing Services or Internet Businesses. The testing services business and the Internet business to be pursued through Cholestech's newly created WellCheck and WellCheck.com businesses are completely new to Cholestech and its management team. To date Cholestech's business has been exclusively in the area of manufacturing and marketing the Cholestech L.D.X(R) System. Cholestech may not be able to successfully develop these new businesses. The demands of attempting to grow these new businesses may prevent Cholestech from devoting significant time and attention to its traditional business, and that traditional business may decline.

Internet Health Management is a new and unproven Business. The internet-based health information management business is a very new and as yet unproven market. Whether Cholestech succeeds in this business will depend upon individual acceptance of internet-based management of personal health information. People may not feel comfortable having their health-related information available over the Internet despite the privacy and security measures Cholestech plans to take.

Cholestech has minimal experience in managing geographically diverse operations. Cholestech's traditional business has been managed and operated almost exclusively from its Hayward, California headquarters. The new WellCheck business Cholestech is adopting will require Cholestech to operate in multiple geographic locations. This will require Cholestech to manage multiple, geographically dispersed businesses and adapt our management and financial systems and controls to this new geographically dispersed business. Cholestech may not be able to manage these changes rapidly, successfully, or at all.

Significant Startup Expenses. The development of the two new business units, and the WellCheck.com Internet business in particular, will require significant start-up expenditures. These expenditures are likely to materially effect the operating results of Cholestech as a whole. The Company may need to seek additional capital to help fund these start-up expenses. The required additional capital may not be available to Cholestech on favorable or acceptable terms when required, or at all. If Cholestech cannot obtain required additional capital, Cholestech may have to change its business strategy, which would be disruptive to its business. If Cholestech raises additional capital through borrowings, the terms of such borrowings may impose limitations on how its management may operate the business in the future. If Cholestech raises additional capital by issuing equity, this may result in a dilution of existing shareholders' interests in Cholestech. Also, equity issued by Cholestech may have rights, preferences, or privileges senior to those of its existing shareholders.

Acquisition Related Risks. The WellCheck business will be developed in significant part by Cholestech acquiring existing testing service businesses. Cholestech may acquire services and/or technology to assist in developing its WellCheck.com business as well. Any such acquisition could result in significant amounts of cash, potentially dilutive issuances of equity securities, and/or the incurring of debt or amortization expenses related to goodwill and other intangible assets, any of which could materially harm our operating results and business.

-0-

Additional risks from the acquisition(s) Cholestech plans may include:

--   Difficulties in assimilating the operations, technologies,
     products, services, and personnel of the acquired company or
     business -- especially assimilating multiple small businesses
     that Cholestech may acquire.

--   The diversion of Cholestech's management's attention from other
     business concerns; and

--   The potential loss of key employees of the acquired company or
     business.

-0-

Internet Business Risks. Cholestech's planned WellCheck.com business will involve the provision and management of individual health-related information over the Internet. Despite security measures Cholestech plans to take, such information may be accessed or manipulated by third parties without Cholestech's, or the individual's consent. Any such security breach could greatly erode consumer confidence in Cholestech's WellCheck.com business and could severely harm that business and its prospects. Additionally, if an individual's health information is corrupted by software or technical problems, consumer confidence in the WellCheck.com business could be severely damaged. If consumer information is altered by third parties or by technical problems, the affected individual may bring litigation against Cholestech and/or the Company's web site hosting partners. Any such litigation could result in significant expense, including any damage awards. Even if ultimately decided in Cholestech's favor, such litigation could result in significant expense and distraction of its management.

Cholestech's recent Annual Report of Form 10-K and Quarterly Report on Form 10-Q and other Securities and Exchange Commission filings discuss some of the important risk factors that may effect Cholestech's business, results of operations, and financial condition. Cholestech undertakes no obligation to revise or update publicly any forward-looking statements for any reason. All such forward-looking statements are current only as of the date on which such statements were made.

Note to Editors: Cholestech L.D.X(R), WellCheck, and WellCheck.com are registered trademarks of Cholestech Corporation. For more information about Cholestech and its products visit us on the web at www.cholestech.com